Parshall B Lynne
Director at CYTK; Director at IONS; Director, 10% owner at Regulus Therapeutics Inc.
- Sold, on record
- $53.3M
- Dollars the filings state
- Form 4 sales
- 86
- Latest Sep 1, 2026
- Form 144 notices
- 17
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- CYTKCYTOKINETICS INCDirector
- IONSIONIS PHARMACEUTICALS INCDirector
- Regulus Therapeutics Inc.Director, 10% owner
Sales by reason
Form 4 sales per year, every sale on record.
Sales by company
- IONS1.3M shares
- CYTK198,445 shares
- Regulus Therapeutics Inc.32,350 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice IONSNoticeFeb 11, 2026 2026
Filed to sell 10,000 shares ($827k)
Parshall B Lynne, Director
10b5-1 plan2x usual sizeFiling
- 2 Form 4 sale IONSRoutineFeb 11, 2026 same day
Sold 5,000 shares at $82.72 ($414k)
Parshall B Lynne, Director
10b5-1 planSold 8.2% of holdings ($5.1M position)56,344 shares left1x usual sizeFollows a Form 144Filing
- 3 Form 4 sale CYTKRoutineMar 2, 2026 +19 days
Sold 5,000 shares at $61.21 ($306k)
Parshall B Lynne, Director
10b5-1 planSold 21.8% of holdings ($1.4M position)17,933 shares left1x usual sizeFollows a Form 144Filing
- 4 Form 144 notice CYTKNoticeMar 2, 2026 same day
Filed to sell 10,000 shares ($622k)
Parshall B Lynne, Director
10b5-1 plan2x usual sizeFiling
- 5 Form 4 sale IONSRoutineApr 15, 2026 +44 days
Sold 5,000 shares at $76.27 ($381k)
Parshall B Lynne, Director
10b5-1 planSold 8.9% of holdings ($4.3M position)51,344 shares left1x usual sizeFollows a Form 144Filing
- 6 Form 4 sale CYTKRoutineJun 1, 2026 +47 days
Sold 5,000 shares at $74.08 ($370k)
Parshall B Lynne, Director
10b5-1 planSold 24.1% of holdings ($1.5M position)15,784 shares left1x usual sizeFiling
- 7 Form 144 notice CYTKNoticeSep 1, 2026 +92 days
Filed to sell 5,000 shares ($355k)
Parshall B Lynne, Director
10b5-1 plan1x usual sizeFiling
- 8 Form 4 sale CYTKRoutineSep 1, 2026 same day
Sold 5,000 shares at $71.48 ($357k)
Parshall B Lynne, Director
10b5-1 planSold 31.7% of holdings ($1.1M position)10,784 shares left1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (103)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Sep 1, 2026 | CYTK | Director | Form 4 sale | 5,000 | $357k | 31.7% | Routine | SEC |
| Sep 1, 2026 | Sep 1, 2026 | CYTK | Director | Form 144 notice | 5,000 | $355k | Notice | SEC | |
| Jun 1, 2026 | Jun 1, 2026 | CYTK | Director | Form 4 sale | 5,000 | $370k | 24.1% | Routine | SEC |
| Apr 15, 2026 | Apr 17, 2026 | IONS | Director | Form 4 sale | 5,000 | $381k | 8.9% | Routine | SEC |
| Mar 2, 2026 | Mar 2, 2026 | CYTK | Director | Form 144 notice | 10,000 | $622k | Notice | SEC | |
| Mar 2, 2026 | Mar 2, 2026 | CYTK | Director | Form 4 sale | 5,000 | $306k | 21.8% | Routine | SEC |
| Feb 11, 2026 | Feb 13, 2026 | IONS | Director | Form 4 sale | 5,000 | $414k | 8.2% | Routine | SEC |
| Feb 11, 2026 | Feb 11, 2026 | IONS | Director | Form 144 notice | 10,000 | $827k | Notice | SEC | |
| Nov 19, 2025 | Nov 19, 2025 | CYTK | Director | Form 144 notice | 5,000 | $331k | Notice | SEC | |
| Nov 19, 2025 | Nov 19, 2025 | CYTK | Director | Form 4 sale | 5,000 | $324k | 17.9% | Routine | SEC |
| Oct 15, 2025 | Oct 16, 2025 | IONS | Director | Form 4 sale | 5,000 | $359k | 7.5% | Routine | SEC |
| Oct 15, 2025 | Oct 15, 2025 | IONS | Director | Form 144 notice | 5,000 | $359k | Notice | SEC | |
| Sep 2, 2025 | Sep 4, 2025 | IONS | Director | Form 4 sale | 20,000 | $1M | 23.2% | Routine | SEC |
| Sep 2, 2025 | Sep 2, 2025 | IONS | Officer | Form 144 notice | 20,000 | $1M | Notice | SEC | |
| Aug 6, 2025 | Aug 8, 2025 | IONS | Director | Form 4 sale | 5,000 | $210k | 5.5% | Routine | SEC |
| Aug 6, 2025 | Aug 6, 2025 | IONS | Officer | Form 144 notice | 10,000 | $419k | Notice | SEC | |
| Sep 9, 2024 | Sep 9, 2024 | CYTK | Director | Form 4 sale | 5,000 | $275k | 19.5% | Routine | SEC |
| Sep 9, 2024 | Sep 9, 2024 | CYTK | Director | Form 144 notice | 5,000 | $275k | Notice | SEC | |
| Aug 26, 2024 | Aug 26, 2024 | CYTK | Director | Form 4 sale | 5,000 | $286k | 19.5% | Routine | SEC |
| Aug 26, 2024 | Aug 26, 2024 | CYTK | Director | Form 144 notice | 5,000 | $286k | Notice | SEC | |
| Aug 12, 2024 | Aug 12, 2024 | CYTK | Director | Form 4 sale | 5,000 | $276k | 19.5% | Routine | SEC |
| Aug 12, 2024 | Aug 12, 2024 | CYTK | Director | Form 144 notice | 5,000 | $276k | Notice | SEC | |
| Jul 29, 2024 | Jul 31, 2024 | CYTK | Director | Form 4 sale | 5,000 | $299k | 19.5% | Routine | SEC |
| Jul 29, 2024 | Jul 29, 2024 | CYTK | Director | Form 144 notice | 5,000 | $299k | Notice | SEC | |
| Jul 15, 2024 | Jul 16, 2024 | CYTK | Director | Form 4 sale | 5,000 | $279k | 19.5% | Routine | SEC |
| Jul 15, 2024 | Jul 15, 2024 | CYTK | Director | Form 144 notice | 5,000 | $279k | Notice | SEC | |
| Jul 1, 2024 | Jul 1, 2024 | CYTK | Director | Form 144 notice | 5,000 | $271k | Notice | SEC | |
| Jul 1, 2024 | Jul 1, 2024 | CYTK | Director | Form 4 sale | 5,000 | $271k | 19.5% | Routine | SEC |
| Jun 17, 2024 | Jun 17, 2024 | CYTK | Director | Form 4 sale | 5,000 | $263k | 19.5% | Routine | SEC |
| Jun 17, 2024 | Jun 17, 2024 | CYTK | Director | Form 144 notice | 5,000 | $263k | Notice | SEC | |
| Jun 3, 2024 | Jun 4, 2024 | CYTK | Director | Form 4 sale | 5,000 | $243k | 24.3% | Routine | SEC |
| Jun 3, 2024 | Jun 3, 2024 | CYTK | Director | Form 144 notice | 5,000 | $243k | Notice | SEC | |
| Dec 28, 2023 | Dec 28, 2023 | IONS | Director | Form 4 sale | 117,638 | $5.9M | 58.8% | Routine | SEC |
| Dec 26, 2023 | Dec 27, 2023 | IONS | Director | Form 144 notice | 117,638 | $6.1M | Notice | SEC | |
| Sep 26, 2023 | Sep 28, 2023 | IONS | Director | Form 4 sale | 10,000 | $451k | 10.8% | Routine | SEC |
| Sep 26, 2023 | Sep 26, 2023 | IONS | Director | Form 144 notice | 10,000 | $451k | Notice | SEC | |
| Sep 1, 2022 | Sep 1, 2022 | CYTK | Director | Form 4 sale | 30,296 | $1.6M | 75.2% | Unusual | SEC |
| Nov 5, 2021 | Nov 5, 2021 | CYTK | Director | Form 4 sale | 30,996 | $1.2M | 86.1% | Unusual | SEC |
| Oct 19, 2021 | Oct 20, 2021 | CYTK | Director | Form 4 sale | 10,332 | $369k | 67.4% | Unusual | SEC |
| Dec 23, 2020 | Dec 28, 2020 | IONS | Director | Form 4 sale | 10,000 | $600k | 14.8% | Plan not stated | SEC |
| Nov 25, 2020 | Nov 30, 2020 | IONS | Director | Form 4 sale | 3,590 | $180k | 5.1% | Plan not stated | SEC |
| Nov 24, 2020 | Nov 25, 2020 | IONS | Director | Form 4 sale | 3,910 | $196k | 5.5% | Plan not stated | SEC |
| Oct 5, 2020 | Oct 6, 2020 | CYTK | Director | Form 4 sale | 50,311 | $1.5M | 100.0% | Unusual | SEC |
| Jun 22, 2020 | Jun 23, 2020 | CYTK | Director | Form 4 sale | 16,510 | $413k | 100.0% | Unusual | SEC |
| Apr 29, 2019 | May 1, 2019 | IONS | Director | Form 4 sale | 50,000 | $3.8M | 48.7% | Unusual | SEC |
| Mar 12, 2019 | Mar 14, 2019 | IONS | Director | Form 4 sale | 8,334 | $625k | 13.7% | Plan not stated | SEC |
| Feb 27, 2019 | Mar 1, 2019 | IONS | Director | Form 4 sale | 8,333 | $583k | 13.7% | Plan not stated | SEC |
| Jan 16, 2018 | Jan 17, 2018 | IONS | Director | Form 4 sale | 5,986 | $310k | 13.6% | Plan not stated | SEC |
| Oct 18, 2017 | Oct 20, 2017 | IONS | COO | Form 4 sale | 16,118 | $1M | 38.5% | Unusual | SEC |
| Mar 1, 2017 | Mar 2, 2017 | IONS | COO | Form 4 sale | 4,625 | $228k | 15.3% | Plan not stated | SEC |